Cite
HARVARD Citation
Wirth, L. et al. (2021). Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer. Journal of clinical oncology. 39 (21), pp. 2359-2366. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wirth, L. et al. (2021). Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer. Journal of clinical oncology. 39 (21), pp. 2359-2366. [Online].